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Abstract: Traditional Irish medicines are often intertwined with ritual and spirituality, making
it difficult to substantiate the validity of their claims. In this manuscript, we use molecular and
microscopic techniques to investigate some microorganisms that might be responsible for the reputed
healing properties of an ancient Irish soil cure known as the Blessed clay from a site in Boho in
the West Fermanagh Scarplands. We previously reported the isolation of an antibiotic producing
bacteria from this soil. In this report, we characterize the antibiotic activity of a further six isolates of
Streptomyces from this source. Two of these isolates inhibit the growth of multi-resistant Staphylococcus
aureus (MRSA) and Pseudomonas aeruginosa, two inhibit the growth of the yeast Starmerella bombicola,
and two have as yet undetermined activity. Genetic analysis of these Streptomyces reveals the potential
to synthesize varieties of antibiotics similar to cypemycin, griseochelin, macrolactams, and candicidin.
From these observations, we suggest that part of the medicinal reputation of the Blessed clay may
lie in the diversity of antimicrobial producing Streptomyces isolated from this soil. These findings
highlight the potential for antibiotic discovery in this area.
Keywords: ethnopharmacology; soil; antimicrobial; streptomyces; antibiotics; MRSA; traditional medicine
1. Introduction
The record of traditional Irish folk medicine, essentially passed on by word of mouth,
is fading from the living landscape. The principal reasons for this are the advancing age
of the population, the sharp decline in the use of traditional medicine, and of course,
the reliability of modern medicines. However, in a reversal of fortune, researchers are
now looking towards traditional medicines as a potential source of new pharmaceutical
compounds [1–5].This necessity is partly due to a reduction in the supply of new antibi-
otics caused by years of under-investment [6,7]. Indeed, the World Health Organization
(WHO), in their Global Pathogen Priority (GPP) catalogue, identified a group of multi-
resistant pathogens, including methicillin resistant Staphylococcus aureus and multi resistant
Pseudomonas aeruginosa, as priority targets for the research and development of new antibi-
otics [8]. These challenges have prompted researchers to pursue more innovative methods
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of drug discovery. One of these approaches, pioneered by Geoffrey Cordell, was the anal-
ysis of traditional folk-medicine. Geoffrey discovered that traditional medicines yielded
far more successful lead compounds in the development of anticancer drugs than random
plant screenings [9]. These ideas were quickly adopted by other researchers. Pioneering
work by the group of Julian Davies in British Columbia discovered that the sacred clay,
used for millennia by the Heiltsuk peoples of Kisameet Bay, was able to combat many
multi-resistant hospital pathogens [3]. In another part of the globe, researchers in Jordan
attributed the therapeutic activity of ‘Red clay’ to a high proportion of antibiotic producing
bacteria found in the soil [10]. Researchers have discovered that antibiotic producing organ-
isms could also have a close relationship with plants. This was the case for Streptomyces sp.
strain Y3111, which lives in association with the traditional Chinese medicinal plant Hera-
cleum souliei and produces anti-tubercular (anti-BCG) compounds named heraclemycins [1].
Some researchers have even reconstituted ancient medicines from old texts that have been
proven to be effective against antibiotic resistant organisms such as methicillin resistant
Staphylococcus aureus (MRSA) [2]. The common theme running through many of these
discoveries has been the presence of Streptomyces. Together with other closely related
genera, these organisms produce as much as 50% of the world’s current antibiotics, as well
as anticancer, antiparasitic, and antifungal compounds [11].
The West Fermanagh Scarplands are a remote range of limestone hills on the border
between N. Ireland and Eire. This area has a long tradition of folk cures associated with
rocks, soils, and wells, some of which are named after the diseases they cure, such as
jaundice, scurvy, and ague. One of the traditional medicines from this area concerns the
soil that covers the grave of a cleric known as Fr McGirr. Fr McGirr belonged to a group of
priests who emerged at the end of the penal laws in Ireland. Many of these people were
familiar with both spirituality and local folk healing practices [12]. In his later years’ Fr
McGirr stated that the soil that covered him would be able to cure the same diseases as it
did when he was alive. This soil or ‘Blessed clay’, as it is described by locals, is wrapped
in cloth and is given for ailments as diverse as toothache or tuberculosis. In our previous
research, we isolated one species of Streptomyces from this soil that inhibited several
antibiotic resistant pathogens [13]. Our current investigation involves the isolation and
characterization of other Streptomycetes isolated from this soil. We also used the antibiotic
prediction software antiSMASH [14,15], in combination with in vitro antimicrobial analysis,
to optimize the potential antimicrobial identification from the genomes of these isolates.
2. Materials and Methods
2.1. Microorganism Strains
Methicillin resistant Staphylococcus aureus (MRSA) (ATCC 43300), Pseudomonas aerug-
inosa (PA01), and Starmerella bombicola were kindly provided by Prof. I.M. Banat (Ul-
ster University). Streptomyces sp. myrophorea isolate McG1 (NCTC 14177, DSM 107716)
was previously isolated from a soil sample in the Boho region of the West Fermanagh
Scarplands and is also referred to as Streptomyces strain McG1 in this manuscript [13].
Streptomyces isolates McG2 up to McG7 were also isolated from the same soil sample,
as described above. One gram of this soil sample was diluted in 1 mL sterile water, vortexed,
and cultured on International Streptomyces Project (ISP) 2 agar (1/5th strength) and starch
agar (Oxoid, Hampshire, UK), as previously described [13]. Streptomyces isolates were
characterized by observing their distinctive colony morphology (small, embedded colonies
with powdery surfaces) on ISP2 media. These species were further identified using whole
genome sequencing. Stocks of these Streptomyces were frozen at –80 ◦C in 18% glycerol
after their initial isolation.
2.2. Antimicrobial Tests
Antimicrobial tests followed a modified agar overlay method [16]. Briefly, an agar
plug/core of Streptomyces that had grown on soy flour mannitol (SFM) agar for 9–15 days
was placed within wells made in 15 mL of 1.5% agar. This was overlaid with Muller–Hinton
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agar containing pre-diluted test organism at 42 ◦C in the case of P. aeruginosa, tryptic soy
agar (TSB) in the case of S. aureus, and Sabouraud dextrose agar in the case of S. bombicola.
In cases where the overlay methods were not consistent, a sterile swab was used to apply a
dilution of 1 × 106 cfu/mL of test organism. Zones of inhibition in the confluent growth of
test pathogens was deemed to indicate antimicrobial activity. Inhibition zones less than
1mm from agar core were recorded as resistant.
Antibiograms followed the Kirby–Bauer protocol [17]. Organisms were grown on
Muller–Hinton agar and tested against a variety of antibiotic discs, which were placed on
top of the agar. Agar plates were incubated overnight at 37 ◦C. The presence of a zone of
inhibition greater than 1 mm from the edge of the disk indicated inhibition.
2.3. Molecular Biology
2.3.1. Genome Sequencing
Genome sequencing of Streptomyces was performed by MicrobesNG (Birmingham,
UK). The DNA was extracted from Streptomyces using a Qiagen DNA extraction Kit 200
(Qiagen, Venlo, The Netherlands) with modifications. A pure culture of Streptomyces grown
on an agar plate was suspended in 500 mL PBS in lysing matrix in a 2 mL tube (MP
biomedical, Santa Ana, CA, USA). Bacterial cells were lysed by fast prep (60 for 40 s (×2).
The suspension was centrifuged, and the supernatant was transferred to 2 mL Eppendorf
tubes. Next, 500 µL of ATL lysis buffer and 80 µL of proteinase were added and incubated
for 10 min at 70 ◦C. A further 16 µL RNase and 500 µL were then added to the buffer and
incubated at 70 ◦C for 7 min. A further 600 µL of ethanol was then added. The suspension
was transferred to the mini spin column and centrifuged at 6010× g for 1 min. This step
was repeated until the whole suspension had passed through. The column was washed
twice, and the DNA was eluted in 50 µL of elution buffer. Extracted DNA was quantified
with a Nano Drop spectrophotometer.
Genomic DNA libraries were prepared using Nextera XT Library Prep Kit (Illumina,
San Diego, CA, USA). The manufacturers protocol was changed slightly by adding two
nanograms of DNA instead of one as an input, and the PCR elongation time was changed
from 30 s to one minute. DNA quantification and library preparation were performed
on a Hamilton Microlab STAR automated liquid handling system. Pooled libraries were
quantified using the Kapa Biosystems Library Quantification Kit for Illumina on a Roche
light cycler 96 qPCR machine. Libraries were sequenced on the Illumina HiSeq using a
250 bp paired end protocol. Reads were adapter trimmed using Trimmomatic 0.30 with a
sliding window quality cut off of Q15 [18]. De novo assembly was performed on samples
using SPAdes version 3.7 [19], and contigs were annotated using Prokka 1.11 [20]. The
genomes of Streptomyces spp. isolates McG2, McG3, McG5, McG6, McG7, and McG8 were
sequenced. The sequence of Streptomyces sp. isolate McG1 was already reported in another
study [13].
2.3.2. Genome Deposition
Whole genome sequences of Streptomyces spp. isolates McG2, McG3, McG5, McG6,
McG7, McG8 were deposited in DDBJ/ENA/GenBank in the Bioproject PRJNA433829 un-
der the following accession numbers: McG2, JAAXYB000000000; McG3, JAAXYC000000000;
McG5: JAAXYD000000000; McG6, JAAXYE000000000; McG7, JAAXYF000000000; and
McG8, JAAXYG000000000. The versions described here are the first versions and have
been assembled to the contig level.
2.3.3. Taxonomic Position of Streptomyces Isolates Using a
Maximum-Likelihood Phylogeny
A multi-locus phylogeny was reconstructed by the method reported previously [13].
Briefly, whole genome sequences (WGS) for all Streptomyces were retrieved autonomously
from GenBank. Genomes were annotated in PROKKA [20], and the resulting translated
coding domain sequences were used to generate a multi-locus, concatenated alignment
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of 400 proteins in PhyloPhlan [21]. Proteins used for the alignment were those shown
to be conserved among bacterial genera [21]. A maximum-likelihood phylogeny was
reconstructed in FastTree and rendered in iTOL [22,23]. The robustness of the phylogeny
was assessed using 1000 bootstrap replications. The phylogeny was reconstructed with 921
Streptomyces genomes (including McG designated isolates). The phylogeny was outgroup
rooted along the lineage leading to Frankia (five species). The full list of species in the
phylogeny can be found in Supplementary Data (File S1). Genome-to-genome distance
calculations were performed in GGDC web server (http://ggdc.dsmz.de/ server accessed
on 22 May 2021) using formula 3 to account for the use of draft genomes.
2.3.4. Secondary Metabolite Analysis
Gene clusters known to be involved in secondary metabolite biosynthesis, self-
immunity, or resistance were identified using Antibiotics and Secondary Metabolite Analy-
sis Shell (anti-SMASH) version 4.0.0 [14]. The relaxed metabolite matching parameter in
antiSMASH was chosen for comparison of the Streptomyces genomes. This detects well-
defined clusters containing all required parts of a biosynthetic gene cluster, as well as partial
clusters missing one or more functional parts. The GenBank sequence files (from Prokka
annotation) were submitted to the web interface selecting all extra features of annotation.
3. Results
3.1. Microbial Characterization
We isolated six Streptomyces from the ‘Blessed clay’ of Fr McGirr, which we labelled
as Streptomyces spp. McG2 to McG8 (herein referred to as McG2 to McG8). These were
identified from colony morphology, microscopy, and whole genome sequencing. We have
previously characterized Streptomyces sp. myrophorea isolate McG1 (NCTC 14177) [13].
Streptomyces spp. McG2 to McG8 grew well on ISP2, PDA, and starch agar. All isolates
were characterized by small, embedded colonies with powdery surfaces that emitted earthy
odors. All of these Streptomyces isolates had a high salt (NaCl) tolerance (Table 1).
Table 1. Characterization of Streptomyces isolates from Boho, County Fermanagh.
Isolate Colonies Spores NaCl (w/v) Tolerance inGrowth Media
Streptomyces sp. isolate McG1 pale green to green green to pale spores to 6%, grows up to 10%
McG2 pale green to green green to pale grows and spores up to 10%
McG3 pale green to green green to pale spores to 6%, grows up to 10%
McG5 pale green to light brown pale green to brown grows and spores up to 10%
McG6 pale green to light brown pale green to brown grows and spores up to 10%
McG7 pale green to light brown white to brown spores to 8%, grows up to 10%
McG8 pale green to light brown brown spores to 6%, grows up to 10%
Microscopically, all Streptomyces isolates were Gram-positive, filamentous, with branch-
ing and aerial hyphae that produced spores.
3.2. Antimicrobial Activities of the Isolated Streptomyces Strains
The antimicrobial activity of the Streptomyces isolates was tested against methicillin
resistant Staphylococcus aureus (MRSA) (ATCC 43300), Pseudomonas aeruginosa (PA 01), and
the yeast Starmerella bombicola on agar plates using a modified version of the Lehrer assay
(Figure 1 and Table 2). The antibiotic resistance profiles of the test organisms are shown in
Table 3.
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Figure 1. Boho Streptomyces spp. isolates McG1, McG2, and McG3 tested for inhibitory activity
against (a) MRSA 43,300 (b) P. aeruginosa (PA01). Isolates McG5 and McG6 tested for inhibitory
activity against (c) S. bombicola. Control wells contain gentamicin (GEN 20 µg), kanamycin (KAN
20 µg), teicoplanin (TE 20 µg), cefoxitin (FOX 20 µg), chlorhexidine (CHG, 40 µg), and control blank
(B). Tests performed three or more times.
Table 2. The inhibitory potential of the Streptomyces isolates from the Boho clay against S. aureus
(MRSA 43300), P. aeruginosa (PA01), and S. bombicola. Inhibition zones recorded in millimeters (mm),
resistant (R). Tests were repeated a minimum of three times.
Isolate P. aeruginosa S. aureus S. bombicola
Streptomyces sp.
isolate McG1 18.3 ± 0.6 17.7 ± 0.6 R
McG2 16.5 ± 0.5 17.3 ± 0.6 R
McG3 19.0 ± 1.0 20.3 ± 0.6 R
McG5 R R 14.7 ± 2.1
McG6 R R 11.3 ± 1.5
McG7 R R R
McG8 R R R
Table 3. The antibiotic resistance profiles of the test organisms S. aureus (MRSA 43300), P. aeruginosa
(PA 01), and S. bombicola. Zones of inhibition less than 1 mm from antibiotic disc (Oxoid) were scored
as resistant. Antibiotic doses in µg. Resistant (R), not applicable (NA).
Antibiotic (µg) S. aureus P. aeruginosa S. bombicola
Teicoplanin 20 13.7 ± 0.6 NA NA
Cefoxitin 20 R NA NA
Gentamicin 20 NA 19.3 ± 0.6 NA
Kanamycin 20 NA 21.7 ± 0.6 NA
Chlorhexidine 40 NA NA 15.0 ± 1.0
Vancomycin 5 17.0 ± 1.0 R NA
Ampicillin 10 R R NA
Ciprofloxacin 1 20 0 ± 1.0 23.0 ± 1.0 NA
Tetracycline 30 33 0 ± 3.0 R NA
3.3. Genome Assembly of Streptomyces Isolates from the Boho Clay
Streptomyces genomes were assembled de-novo by MicrobesNG (Birmingham Univer-
sity, Birmingham, UK). The k-mer spectrums of contigs larger than 2000 bp were calculated
based on an approach described previously [24]. For four of the isolates, sets of low cover-
age contigs with k-mer spectrums significantly different from the five largest contigs in the
assembly were identified as probable contaminants. All small contigs of less than 500 bp
were removed from the assemblies (Table 4).
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Table 4. Summary statistics of the genomes of Streptomyces isolates. Number of biosynthetic gene
clusters is based on antiSMASH analysis.







McG2 6.912 1189 9.0 70.7 25
McG3 8.720 586 23.6 125.6 39
McG5 7.026 1079 11.8 70.7 27
McG6 6.874 1524 7.3 62.2 24
McG7 7.143 465 26.0 82.9 12
McG8 7.304 653 18.3 62.7 12
3.4. Prediction of Antibiotic Gene Cluster Similarities
The potential of the Streptomyces isolates to produce antibiotics and other secondary
metabolites was predicted using antiSMASH (version 4), which compared our unknown
gene sequences with previously documented antibiotic/secondary metabolite biosyn-
thetic gene clusters (BGC). These BGCs contain the genes necessary to produce secondary
metabolites, including enzymes and pathway-specific regulatory genes.
We identified many BCGs in the genomes of the six strains of Streptomyces from the
Blessed clay using antiSMASH. Many of the gene cluster similarities identified are common
in Streptomyces, including albaflavenone (a sesquiterpene antibiotic) [25], alkylresorci-
nol [26], desferrioxamine (a siderophore that mitigates cytotoxicity to doxorubicin) [27], ec-
toine [28], isorenieratene (a bacterial chlorophyll) [29], and melanin [30]. These compounds
are recorded here because of their potential synergy with antibiotics [31]. Most importantly,
there were also similarities between the gene sequences we identified in these Streptomyces
and several antibiotic gene synthesis clusters, including those for polycyclic tetramate
macrolactams (SGR PTM), candicidin, griseochelin, cypemycin, and cyslabdan [31–35]
(Table 5).
Table 5. Biosynthetic gene cluster (BGC) similarities between Streptomyces isolates and known antimicrobial synthesis
genes. The biosynthetic gene clusters are hyperlinked to their corresponding matches in the Minimum Information about a
Biosynthetic Gene cluster (MIBiG) repository. Abbreviation: Streptomyces griseus polycyclic tetramate macrolactam (SGR
PTM). * Streptomyces sp. McG1 [14].
Gene Cluster Shared BGC Data Link Streptomyces Isolates McG
1 * 2 3 5 6 7 8
Cypemycin 77% BGC0000582_c1 4 4 4
Candicidin A 66% BGC0000034_c1 4 4 4
Griseochelin 84% BGC0001821_c1 4 4
SGR_PTMs 83% BGC0001043_c1 4 4
Cyslabdan 81% BGC0001910_c1 4 4
AntiSMASH identified several gene clusters in whole genome sequences of Strep-
tomyces isolates McG1 and McG5 with similarities to the lantibiotic cypemycin (77%)
(Figure 2a).
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Figure 2. Biosynthetic cluster similarities between Streptomyces McG isolates and known antibiotic
genes for (a) cypemycin, (b) griseochelin, (c) SGR PTM, and (d) candicidin.
Genes from Streptomyces sp. McG3 showed similarities to the griseochelin (zin-
cophorin) biosynthesis cluster (Figure 2b). Boho Streptomyces sp. isolates McG1 and
McG3 had similar gene sequences to biosynthesis clusters for SGR PTM, a polytetramic
macrolactam [36] (Figure 2c). Streptomyces strains McG2, 5, and 6 had gene similarities
to biosynthesis clusters for candicidin, an antifungal antibiotic [37] (Figure 2d). Finally,
the WGS of Streptomyces isolates McG7 and McG8 showed similarities to gene clusters for
cyslabdan [32].
3.5. Streptomyces Isolate Phylogeny
The relationships between the Streptomyces isolates from the Boho clay were calculated
using the maximum-likelihood of relatedness. This placed isolates McG2, McG5, and McG6
alongside the S. albidoflavus clade, suggesting that these were likely variants (Figure 3a).
Indeed, GGDC calculations supported this, showing that isolates McG2, McG5, and McG6
were closely related to other S. albidoflavus strains with DDH scores of 90, 94, and 90, re-
spectively. Moreover, probability scores of being the same species (i.e., S. albidoflavus) being
>99% in all cases. Phylogenetically, Streptomyces isolate McG3 (Figure 3b) sits alongside
Streptomyces sp. CNB-091, a marine Streptomyces [38].
Figure 3. Phylogenetic relationships between (a) Streptomyces isolates McG2, McG5, and McG6;
(b) Streptomyces isolate McG3; and (c) Streptomyces isolates McG7 and McG8 using maximum-
likelihood phylogeny. Phylogenies were reconstructed in FastTree MP and rendered in iTOL.
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The closest species to Streptomyces sp. McG7 and McG8 was Streptomyces sp. FxanaD5
(Figure 3c). These new isolates were added to the data set of [5,13]. The full phylogeny is
available from the authors on request.
4. Discussion
There has been an increasing interest in the potential of traditional medicines to
provide new medicines over the past few decades [3]. However, many of the older tradition
medicines are hard to decipher because of their complicated relationship with rituals and
mythology. Using a series of microbiological methods, we isolated a group of Streptomyces
from the Blessed clay of Fr McGirr in the West Fermanagh Scarplands. Several of these
isolates inhibited the growth of multi-resistant pathogens and yeasts. These add to the
growing list of Streptomyces sp. isolated from traditional medicines that are able to produce
antibiotics against fungi and bacteria [39]. We were also able to predict the potential
synthesis of a variety of antimicrobial substances from these isolates. We think that these
discoveries may provide a possible explanation as to why this soil has historically been
used as a folk medicine. There is also the possibility that other types of bacteria could also
be associated with the reputed antimicrobial activity of this soil; however, in this study we
concentrated solely on Streptomyces. Additionally, the activity of the Blessed clay could
equally be based on some type of clay mineral, such as Montmorillonite [40,41] or sulfur-
and iron-reducing bacteria [42]. However, the Blessed clay in this study has a silty-loam
consistency rather than clay-like, similar to the rest of the soil found in this area.
Given the continuous spiritual significance of this site, we assume many of the folk
medicines found in this area are derived from much older cultures. Since this particular
traditional soil medicine was passed down by word of mouth, we are still uncertain of
the conditions under which it could yield its full therapeutic potential. Therefore, even
though we managed to induce the production of antibiotics from Streptomyces isolated
from this soil under laboratory conditions, this might still not be the complete repertoire of
its activity.
We are aware that limestone areas similar to Boho have long been regarded as a rich
source of antibiotic producing Streptomyces [43–45]. The Streptomyces species identified from
the Blessed clay sample is grouped into three main clusters. Streptomyces spp. McG7 and
McG8 were found to be closely related to both Streptomyces sp. FxanaD5 and S. griseorubens
JSD-1. Streptomyces sp. isolate McG3 was found to be closely related to Streptomyces sp.
CNB-091, a marine Streptomyces 38]; S. griseus subsp griseus NRRL B 2682; and Streptomyces
sp. McG1 (Streptomyces sp. myrophorea) [13]. In the last grouping, Streptomyces spp.
isolates McG2, McG5, and McG6 were closely related to S. albidoflavus. In many cases, these
Boho Streptomyces isolates were closely related to marine species.
In terms of antibiotic potential of the Boho clay isolates, antiSMASH software predicted
that Streptomyces isolates McG2, McG5, and McG6 had biosynthetic gene clusters similar to
those for candicidin, an antifungal compound [37]. It has been reported that the majority
of isolates exclusively producing candicidin come mainly from which matches with the
identity of Streptomyces sp. isolates McG2, McG5, and McG6 [46]. However, our in vitro
inhibition tests showed that only Streptomyces isolates McG5 and McG6 expressed anti-
fungal activities, whilst McG2 did not show any activity.
In vitro testing showed that only Streptomyces isolates McG1, McG2, and McG3 had
any inhibitory effect on multi-resistant bacteria. The identities of the compounds responsi-
ble for this activity were difficult to discern from the antiSMASH predictions since there
were several biosynthetic gene clusters identified for each isolate. Streptomyces isolates
McG1 and McG3 encoded antibiotic synthesis clusters similar to Streptomyces griseus poly-
tetramic macrolactam (SGR PTM), an antifungal and antioxidant [36]. Streptomyces isolates
McG1 and McG3 also encoded gene synthesis clusters similar to those of griseochelin
(zincophorin), a carboxylic acid antibiotic that is active against Gram-positive bacteria
and viruses. Streptomyces isolates McG1 and McG5 also have gene synthesis clusters for
cypemycin, a Gram-positive antibiotic that also has activity against leukemia [34]. Finally,
Appl. Sci. 2021, 11, 4923 9 of 11
a gene cluster from Streptomyces isolates McG7 and McG8 showed similarity to those
previously identified for the synthesis of cyslabdan, an antimicrobial potentiator [33]. Sev-
eral researchers have also shown that some species of Streptomyces that only produce low
levels of antibiotic when cultivated alone are able to induce other species to express new
antibiotics [47]. This may be an interesting direction to follow in future research.
Altogether, the Streptomyces species isolated here are effective against multi-resistant
bacteria and fungi. It may be possible that this spectrum might extend to anticancer
and antiviral activity, but this is still the subject of ongoing research. This new source of
Streptomyces strains may be a useful resource in helping to replenishing the ever-decreasing
range of antibiotics capable of combating multi-resistant microbial pathogens.
5. Conclusions
We identified a group of Streptomyces from the Blessed clay in the Boho region of West
Fermanagh. We have shown through genome analysis and by in vitro tests that some of
these Streptomyces have the ability to produce antimicrobial compounds that inhibit the
growth of clinically significant multi-resistant pathogens in vitro. We do not know how
to activate this soil in situ, but we feel that the abundance of Streptomyces discovered in
the Boho clay might be responsible for its reputed healing abilities. We think that these
findings might provide a basis for future antibiotic discovery.
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